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ABSTRACT
Background: Details of the comparisons between airway and peripheral blood regulatory T cells (Tregs) in
patients with atopic asthma are still unclear. The objective of this study is to investigate the profiles of both air-
way and circulating Tregs in atopic asthma.
Methods: We measured the numbers of Tregs and eosinophils in induced sputum and peripheral blood in 28
patients with mild atopic asthma and compared these with numbers in 18 healthy controls. The frequency (%)
of Tregs (surface CTLA4+, intracellular Foxp3+, and CTLA4+Foxp3+ on CD25highCD4+ T cells) in sputum and
blood was determined by intracellular 5-color flow cytometry. We also correlated the numbers with the level of
airway hyperresponsiveness (AHR) in asthmatics.
Results: The mean frequencies of cells expressing CTLA4+ (19.4 ± 2.1%, p = 0.075), Foxp3+ (16.4 ± 3.3%, p
= 0.001), and CTLA4+Foxp3+ (7.0 ± 1.1%, p = 0.008) in induced sputum from asthmatics were significantly
lower than controls (27.2 ± 3.7%, 37.4 ± 4.7%, and 18.2 ± 3.6%, respectively), whereas in peripheral blood,
there was no inter-group difference in the frequencies of cells expressing CTLA4+ (7.1 ± 1.5% vs 5.7 ± 1.7%, p
> 0.05), Foxp3+ (35.7 ± 3.2% vs 21.1 ± 3.9%, p > 0.05), and CTLA4+Foxp3+ (6.6 ± 1.5% vs 4.2 ± 1.0%, p >
0.05). Moreover, the frequency of CD25highCD4+ cells expressing CTLA4+, but not Foxp3+, in induced sputum
was associated with AHR (r = 0.60, p = 0.009) and airway eosinophilic inflammation (r = -0.60, p = 0.008) in
asthmatics.
Conclusions: Airway, but not circulating, Tregs are decreased in mild atopic asthmatics, and are negatively
correlated to an increase of airway eosinophilic inflammation and AHR.
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ABBREVIATIONS
AHR, airway hyperresponsiveness; BALF, bronchoalveolar lavage fluid; CTLA4, cytotoxic T-lymphocyte anti-
gen 4; FEV1, forced expiratory volume in 1 second; FSC, forward scatter; Foxp3, forkhead box P3; GINA,
Global Initiative for Asthma; IgE, immunoglobulin E; MCh, methacholine; PBMC, peripheral blood mononuclear
cells; PC20, provocative concentration of methacholine causing a 20% fall in forced expiratory volume in 1 sec-
ond; SEM, standard error of the mean; SSC, side scatter; Th, helper T cell; Tregs, regulatory T cells.
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INTRODUCTION
It is known that forkhead box P3 (Foxp3)-positive
regulatory T cells (Tregs) are potent mediators of
dominant self-tolerance.1 Tregs have the potential to
suppress both Th1- and Th2-induced inflammation.2,3
Activation and expansion of Tregs may be exploited
for treatment of immunologic diseases such as aller-
gic asthma.4 Cytotoxic T-lymphocyte antigen 4
(CTLA4) is a homolog of CD28, which is expressed
only on activated T cells, and binds to the accessory
molecules B7-1 (CD80) and B7-2 (CD86).5,6 CTLA4+
CD4+CD25+ T cells also have the characteristics of
Tregs that down-regulate Th1 and Th2 responses
though CTLA4 signaling.7 It is well known that
CTLA4 express both surface and cytoplasm on cells.
The surface CTLA4 expressing on T cells have im-
munosuppressive effects.8,9 Surface CTLA4 also play
as a sequester for B7 molecules without cytoplasmic
CTLA4 and the sequestration is regulated by the lev-
els of surface expression of CTLA-4.10
We have already demonstrated that in patients with
atopic asthma, allergen inhalation challenge induces
an immediate reduction in the frequency of surface,
but not intracellular, expressed CTLA4+CD4+CD25+
cells in induced sputum from subjects who develop
allergen-induced isolated early responses, and that
this returns to the baseline within 24 h. In contrast,
subjects who develop allergen-induced dual re-
sponses have lower baseline levels of these cells,
which do not change after inhaled allergen chal-
lenge,11 and the number of such cells in induced spu-
tum increases after treatment with inhaled corti-
costeroids.12 Provoost and coworkers13 have demon-
strated that peripheral Tregs are decreased in asth-
matics. In addition, a study of asthmatic children has
demonstrated that Tregs in bronchoalveolar lavage
fluid (BALF) are decreased in comparison with con-
trol children.14 Conversely, it has been reported that
Tregs in BALF are increased in adults with asthma,
and even mild asthma, relative to healthy controls.15
Also, a previous study has demonstrated that Tregs
were more numerous in BALF after allergen provoca-
tion than before challenge.16
CD25 +CD4 + cells have two phenotypes :
CD25highCD4+ cells and CD25lowCD4+ cells.
CD25highCD4+ cells have immunosuppressive func-
tions, whereas CD25lowCD4+ cells are activated effec-
tor or memory T cells that lack the immunosuppres-
sive functions as Tregs.17,18 In this study, to investi-
gate the profiles and roles of all three Treg pheno-
types in atopic asthma, we have compared the rela-
tive frequencies of intracellular Foxp3+ (Foxp3+), sur-
face CTLA4+ (CTLA4+), and Foxp3+CTLA4+ cells
among CD25highCD4+ and CD25lowCD4+ cells in in-
duced sputum and peripheral blood, in steroid-naïve,
non-smoking patients with mild atopic asthma, with
the frequencies in non-atopic healthy subjects (con-
trols), and examined the correlations between each
phenotype and eosinophilic inflammation, lung func-
tion, and airway hyperresponsiveness (AHR) in asth-
matics.
METHODS
SUBJECTS
Twenty-eight non-smoking patients with stable, mild
atopic asthma [female : male = 10 : 18, age range 24
to 45 yr] and 18 non-smoking, non-atopic, and age-
and sex-matched controls [female : male = 6 : 12, age
range 27 to 43 yr] were enrolled (Table 1). All of the
asthmatics were steroid-naïve and had used only
short-acting β2-agonists (SABA) intermittently for
treatment of their asthma. None of them had used
SABA, inhaled or systemic corticosteroids, long-
acting β2-agonists (LABA), leukotriene receptor an-
tagonists (LTRA), theophylline, anti-histamines, or
anti-IgE antibody for at least 4 weeks prior to the
study. None of the subjects had received allergen im-
munotherapy. Patients were excluded had suffered
asthmatic exacerbations or airway infections during
the previous 4 weeks. Diagnosis of asthma and its se-
verity was based on the Global Initiative for Asthma
(GINA) guidelines.19
STUDY PROTOCOL
Each subject underwent a medical interview and ex-
amination, chest radiography, electrocardiography,
and spirometry training at the screening visit (visit 1).
Blood tests, spirometry, AHR to methacholine
(MCh), and sputum induction were conducted at be-
tween 8:00 and 9:00 am on visit 2 within 14 days after
visit 1. Atopy was identified from the values of serum
total IgE (cut-off value for atopy >250 IUL) and lev-
els of IgE against several specific allergens (Dermato-
phagoides farina, Dermatophagoides pteronyssinus,
house dust mite, Candida spp., Aspergillus spp., and
Japanese cedar pollen) determined using commercial
kits (DPC-Immulyze Total IgE IIIⓇ and Immulize
2000Ⓡ, Mitsubishi Kagaku Iatron, Tokyo, Japan).
Atopy was diagnosed from the patient’s history of
atopic diseases and symptoms, a total IgE level of
>250 IUL, andor positive results for IgE against the
specific allergens.
The study was performed in accordance with the
Declaration of Helsinki and Good Clinical Practice
guidelines. Approval (No. 10089) was obtained from
the regulatory agency and human ethics committee
of Kurume University, Japan, and all the patients pro-
vided written informed consent.
SPIROMETRY
Spirometry was performed as previously reported20,21
and repeated 3 times, the best value being adopted.
Subjects were required to have a forced expiratory
volume in 1 second (FEV1) of greater than 80% of the
predicted value. AHR was expressed as PC20 MCh
Profiles of Tregs in Mild Asthma
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Table　1　Characteristics of asthmatics and controls
Mild asthma Control p value
Number of subjects 28 18
Age, yr
(Range)
 33.3 ± 2.1
(24 to 45)
 31.0 ± 1.9
(27 to 43)
NS
Female : Male† 10 : 18 6 : 12 NS
Atopy : Non-atopy† 29 : 0 0 : 18 <0.0001
% FEV1 predicted (%)  93.7 ± 3.2 114.7 ± 4.3 0.0005
PC20 to MCh‡ (mg/mL)   2.4 ± 2.3 >16 <0.0001
No. of sputum Eos. (×103/mL)  210.7 ± 51.6  18.7 ± 8.4 0.0011
No. of blood Eos. (/mL)  293.3 ± 45.8   93.2 ± 10.9 0.0004
Total IgE levels (IU/L)  1,089 ± 314   31 ± 10 0.0004
Patients were excluded had suffered asthmatic exacerbations or airway infections during the previous 4 weeks. Diagnosis of asthma and 
its severity was based on the Global Initiative for Asthma guidelines.16
All data were expressed as mean ± SEM.
†Data were compared using Fisher’s Exact test.
‡Geometric means ± GSEM.
FEV1, forced expiratory volume in 1 second; PC20, provocative concentration of MCh causing a 20% fall in FEV1; MCh, methacholine; 
Eos, eosinophils; NS, not signifi cant.
(the provocative concentration of MCh causing a 20%
fall in FEV1). The predicted values were calculated
using the formula for Japanese.21
MCh INHALATION CHALLENGE
The MCh inhalation challenge was performed using
the method described by Cockcroft and colleagues.22
Briefly, subjects inhaled through a mouthpiece at-
tached to an ultrasonic nebulizer. Normal saline, fol-
lowed by doubling concentrations of MCh, were
nebulized and supplied for 2 minutes each. FEV1 was
measured at 30, 90, 180, and 300 s after each inhala-
tion using an electronic spirometer (Chestgraph Jr
HI-101, CHEST, Tokyo, Japan). The test was termi-
nated when FEV1 had fallen to a level at least 20% be-
low the baseline measurement. The concentration of
MCh required to achieve a MCh PC20 was calculated
through linear interpolation of the percentage fall in
FEV1 against the log-transformed MCh concentra-
tion.22
INDUCED SPUTUM
Sputum was induced using the method described by
Pin and colleagues.23 Briefly, after inhaling 200 μg of
SalbutamolⓇ (GlaxoSmithKline, Tokyo, Japan), sub-
jects inhaled an aerosol of 3%, 4%, and 5% hypertonic
saline for 7 min each from an ultrasonic nebulizer
(NE-U07, Omron, Tokyo, Japan). After each inhala-
tion period, the subjects expectorated sputum into a
container.
The induced sputum was processed as described
by Pizzichini and colleagues.24 The sputum was ac-
cepted when total amount of 600 mg and over was ob-
tained in each subject. Briefly, 4 parts 0.1% dithiothre-
itol (Sputolysin, Calbiochem, CA, USA) was added to
1 part sputum and incubated for 15 min, then 4 parts
phosphate-buffered saline (PBS) was added. Total
cell counts were determined using a hemocytometer
and expressed as the number of cells per milliliter of
sputum after trypan-blue staining. Sputum cells were
pelleted by centrifugation and the supernatant was re-
moved. The cell pellets were then resuspended in
PBS at 0.75 to 1.0 × 106ml, and cytospins were pre-
pared using a Shandon III cytocentrifuge (Shandon
Southern Instruments, Sewickly, PA, USA). Slides
were stained using the May-Giemsa method, and a
1,000 differential cell counts was performed on each
slide by a single observer blind to the clinical data;
the mean count from two slides per subject was used
for analysis. However, data for sputum samples con-
taining >30% epithelial cells and >10% dead cells were
not included. The mean frequency (range) of dead
cells in asthmatics and controls was 4.1 (0.0 to 8.5%)
and 5.2 (1.9 to 8.5%), respectively. Remaining cells
were used for flow cytometry.
PERIPHERAL BLOOD
Total white blood cell counts were calculated using a
hemocytometer, and differential cell counts were ob-
tained from blood smears using the same method as
that for the sputum slides. Cell populations were ex-
pressed as the number per milliliter. Peripheral blood
mononuclear cells (PBMC) were isolated for flow cy-
tometry on an AccuprepTM (Accurate Chemical and
Scientific, Westbury, NY, USA) density gradient.
There were >99.9% of live cells of PBMC in both of
asthmatics and controls by trypan-blue staining.
FLOW CYTOMETRY
Cells were incubated in 5% normal mouse serum
(Sigma) for 10 min, then washed in PBS. This was fol-
lowed by 5-color and intracellular staining with anti-
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Fig.　1a　Detection of Tregs in induced sputum by fl ow cytometry. Panels 
show the areas of lymphocytes plotted between the SSC and FSC axes, 
and the areas of CD4+CD3+ (CD4+) cells plotted between the ECD-CD3 
and PC7-CD4 axes for sputum and peripheral blood (PBMC). SSC, side 
scatter; FSC, forward scatter; PBMC, peripheral blood mononuclear cells.
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human R phycoerythrin-Texas RedⓇ-X (ECD, Energy
Coupled Dye)-conjugated CD3 (Beckman Coulter,
CA, USA), phycoerythrin-Cy7 (PC7)-conjugated CD4
(Beckman Coulter), phycoerythrocyanin 5.1 (PC5)-
conjugated CD25 (Beckman Coulter), fluorescent iso-
thiocyanate (FITC)-conjugated Foxp3 (eBioscience,
CA, USA), phycoerythrin (PE)-conjugated CD152
(CTLA4) (PharMingen, CA, USA) antibodies. Briefly,
isolated cells were stained with PE-CD152, ECD-
CD3, PC5-CD25, PC7-CD4 antibodies, andor control
isotype-matched antibodies. The cells were treated
with 1% paraformaldehyde and 0.1% saponin. Then,
the cells were further stained with FITC-Foxp3 anti-
bodies, andor control isotype matched antibodies. A
flow cytometer (Cytomics 500, Beckman Coulter)
equipped with a 15-mA argon ion laser and filter set-
tings for FITC (525 nm) (FL-1), PE (575 nm) (FL-2),
ECD (620 nm) (FL-3), PC5 (675 nm) (FL-4), and PC7
(650 nm) (FL-5) was used. All events were acquired
in list mode with debris excluded by the forward scat-
ter threshold.
The area of lymphocytes and CD4+ (CD3+CD4+)
cells in both induced sputum and peripheral blood af-
ter preparation of thresholds to remove the area of
debris or dead cells was gated with the forward and
side scatter described by Yoshida and coworkers
(Fig. 1a).25 The area of CD25+ cells among CD4+ cells
was recognized by control isotype matched antibod-
ies. The borderline between CD25high and CD25low
cells was defined as lying within the area of CD25+
CD4−CD3+ cells that represented the 1% of the area of
CD3+ cells gated along the CD4 and CD25 axis, as
CD25+CD4−CD3+ cells were low positive for CD25+
(CD25low), but not CD25highCD4+ antigen, in accor-
dance with previous reports.17,26,27 The frequency of
each subpopulation such as CD25high and CD25low
cells on CD4+ cells was determined (Fig. 1b). The fre-
quency of CD25+ cells among CD4+ cells was deter-
mined as both the areas of CD25high and CD25low
cells. Figure 1c shows the area of CTLA4+, Foxp3+,
and CTLA4+Foxp3+ cells on panels of PE and FITC
axes. The frequency of CTLA4+ cells was calculated
as the frequency of CTLA4+Foxp3− plus CTLA4+
Foxp3+ cells, and the frequency of Foxp3+ cells was
also calculated as the frequency of CTLA4−Foxp3+
plus CTLA4+Foxp3+ cells. (Fig. 1d). Three hundred
and over events recognized the CD25+CD4+ cells
were acquired from each sample. The cutoff level for
definition of positive cells was less than 2% of cells
positively stained with mouse or rat isotype control
antibodies (Beckman Coulter). The data were ana-
lyzed using the Flow-JoⓇ software package for Win-
dows (Tomy Digital Biology, Tokyo, Japan).
STATISTICAL ANALYSIS
Unless otherwise stated, all results were expressed
as the mean ± standard error of the mean (SEM). Val-
ues of MCh PC20 were log-transformed prior to analy-
sis and were reported as geometric means ± SEM
(GSEM).22 Paired t-tests were used with correction
by Wilcoxon matched-pairs single rank test. Correla-
tions were determined by Spearman’s rank correla-
tion test. All comparisons were two-tailed, and p val-
ues of <0.05 were considered significant. JMP version
9 for Windows (SAS Institute, Cary, NC, USA) was
used for data analysis.
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Fig.　1b　Detection of Tregs in induced sputum by fl ow cytometry. Areas of CD25high and 
CD25low CD4+ cells defi ned in accordance with the isotype control and CD25+CD3+ cells in in-
duced sputum and PBMC from asthmatics and controls. SSC, side scatter; FSC, forward scatter; 
PBMC, peripheral blood mononuclear cells.
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Fig.　1c　Detection of Tregs in induced sputum by fl ow cytometry. Tregs 
were divided into three phenotypes, namely CTLA4+, Foxp3+, and 
CTLA4+Foxp3+ cells among CD25high, CD25low or CD25+CD4+ cells in in-
duced sputum and PBMC from asthmatics and controls. SSC, side scatter; 
FSC, forward scatter; PBMC, peripheral blood mononuclear cells.
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RESULTS
COMPARISON OF CHARACTERISTICS BE-
TWEEN ASTHMATICS AND CONTROLS
All of the asthmatics had atopy and mild asthma
(%FEV1 pred. >80%), whereas all of the controls had
no respiratory symptoms. As expected by the selec-
tion of the subjects, the %FEV1 in asthmatics was sig-
nificantly lower than that in controls (p = 0.001), and
the MCh PC20 values in asthmatics was significantly
lower than in controls (p < 0.0001). The absolute
number of eosinophils in asthmatics was significantly
higher than in controls in both induced sputum and
peripheral blood (p < 0.005 and p = 0.0004, respec-
tively) (Table 1). However, there was no significant
inter-group difference in the total cell counts or other
differential cells counts (data not shown).
CD25high, CD25low AND CD25+ CELLS ON CD4+
CELLS IN INDUCED SPUTUM AND PERIPHERAL
BLOOD IN ASTHMATICS AND CONTROLS
In both asthmatics and controls, the frequency of
CD25high, CD25low and CD25+ cells among CD4+ cells
in induced sputum was significantly higher than in
peripheral blood (p < 0.0001) (Table 2). In peripheral
blood, the frequency of CD25high (p <0.05), but not
Kawayama T et al.
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Fig.　1d　Detection of Tregs in induced sputum by fl ow cytometry. Each pheno-
type of Tregs was recognized the percentages of events in bold boxes as the 
frequency of CTLA4+, Foxp3+, and CTLA4+Foxp3+ cells, respectively. SSC, side 
scatter; FSC, forward scatter; PBMC, peripheral blood mononuclear cells.
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Table　2　The frequency of CD25high, CD25low, and CD25+ cells among CD4+ cells in induced sputum and peripheral blood from
asthmatics and controls
Mild asthma
(n = 28)
Control
(n = 18)
Specimens Sputum Blood Sputum Blood
%CD25high cells 19.4 ± 1.8*   9.1 ± 1.2** 22.8 ± 2.0* 4.4 ± 0.5
%CD25low cells 16.5 ± 1.1*  3.6 ± 0.3 14.2 ± 0.6* 3.7 ± 0.3
%CD25+ cells 36.8 ± 2.5* 12.7 ± 1.5 36.5 ± 2.5* 8.1 ± 0.7
All data were expressed as mean ± SEM.
*p < 0.001 induced sputum vs peripheral blood from asthmatics or controls.
**p < 0.05 asthmatics vs controls in peripheral blood.
CD25low and CD25+ cells among CD4+ cells, was
higher in asthmatics than in controls, whereas there
was no significant inter-group difference in the fre-
quency of CD25high, CD25low and CD25+ cells among
CD4+ cells in induced sputum (Table 2).
TREGS AMONG CD25high AND CD25lowCD4+
CELLS IN INDUCED SPUTUM AND PERIPHERAL
BLOOD FROM ASTHMATICS AND CONTROLS
Among CD25highCD4+ cells in induced sputum, the
frequency of CTLA4+ (19.4 ± 2.1%, p = 0.075), Foxp3+
(16.4 ± 3.3%, p = 0.001), and CTLA4+Foxp3+ (7.0 ±
1.1%, p = 0.008) cells in asthmatics were lower than
those in controls (27.2 ± 3.7%, 37.4 ± 4.7%, and 18.2 ±
3.6%, respectively), whereas there was no significant
inter-group difference in the frequencies of CTLA4+
(7.1 ± 1.5% vs 5.7 ± 1.7%, p > 0.05), Foxp3+ (35.7 ± 3.2%
vs 21.1 ± 3.9%, p > 0.05), and CTLA4+Foxp3+ (6.6 ±
1.5% vs 4.2 ± 1.0%, p > 0.05) in peripheral blood (Fig. 2
a). Asthmatics had a higher frequency of CTLA4+ (p =
0.002) cells and a lower frequency of Foxp3+ (p =
0.011) cells, whereas controls had higher frequencies
of CTLA4+ (p = 0.001), Foxp3+ (p = 0.024) and
CTLA4+Foxp3+ (p = 0.004) cells in induced sputum
than in peripheral blood (Fig. 2a).
Among CD25lowCD4+ cells in induced sputum,
there were no significant differences in the frequen-
cies of CTLA4+ cells (8.3 ± 2.1% vs 10.5 ± 1.9, p >
0.05), Foxp3+ (13.8 ± 4.8% vs 21.0 ± 4.3, p > 0.05), and
CTLA4+Foxp3+ (2.3 ± 0.8% vs 5.1 ± 1.6, p > 0.05) be-
tween asthmatics and controls. There were also no
significant inter-group differences in the frequencies
of CTLA4+ cells (3.1 ± 2.1% vs 1.2 ± 0.2%, p > 0.05),
Foxp3+ cells (16.0 ± 4.5% vs 10.4 ± 2.7%, p > 0.05), and
CTLA4+Foxp3+ cells (2.7 ± 1.2% vs 0.6 ± 0.1%, p > 0.05)
in peripheral blood (Fig. 2b). Controls had higher fre-
quencies of CTLA4+ cells (p = 0.003), Foxp3+ (p =
0.087) and CTLA4+Foxp3+ cells (p = 0.022) in induced
sputum than in peripheral blood, whereas asthmatics
showed no significant differences in the frequencies
of CTLA4+ cells (p > 0.05), Foxp3+ cells (p > 0.05) and
CTLA4+Foxp3+ cells (p > 0.05) between induced spu-
tum and peripheral blood (Fig. 2b).
The frequency of CTLA4+, Foxp3+, and CTLA4+
Foxp3+ cells on CD25highCD4+ cells were significantly
higher than that of each cells on CD25lowCD4+ cells
in both induced sputum and peripheral blood in asth-
matics and controls (all p < 0.05, respectively) (Fig. 2
a, b).
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Fig.　2　CD25high and CD25lowCD4+ Tregs in induced sputum and peripheral blood of asthmatics 
and controls. a) The mean (error bar = SEM) frequencies of CTLA4+, Foxp3+, and 
CTLA4+Foxp3+cells among CD25highCD4+ cells in induced sputum and peripheral blood from asth-
matics (black bars) and controls (white bars). b) The mean (error bar = SEM) frequencies of 
CTLA4+, Foxp3+, and CTLA4+Foxp3+ cells among CD25lowCD4+ cells in induced sputum and pe-
ripheral blood from asthmatics (black bars) and controls (white bars). *p < 0.05, **p < 0.01 asth-
matics vs controls for each phenotype in induced sputum or peripheral blood. †p < 0.05, ‡ p < 
0.01 induced sputum vs peripheral blood for each phenotype in asthmatics or controls.
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CORRELATIONS BETWEEN TREGS, EOSINO-
PHILIC INFLAMMATION, LUNG FUNCTION, AND
AHR IN ASTHMATICS
In the asthmatic subjects, the absolute number of
sputum eosinophils was significantly correlated with
MCh PC20 (r = -0.69, p = 0.007), but not with %FEV1
pred. (r = -0.25, p > 0.05), whereas there was no corre-
lation between peripheral blood eosinophils and MCh
PC20 (r = 0.21, p > 0.05) or %FEV1 pred. (r = 0.15, p >
0.05). Among the Treg phenotypes, only CTLA4+
Foxp3+ cells in induced sputum were significantly as-
sociated with lung function (%FEV1 pred.) (r = 0.56, p
= 0.02) (Table 3).
The frequency of CTAL4+ cells (r = -0.60, p =
0.008), but not Foxp3+ cells (r = -0.25, p > 0.05), in in-
duced sputum among CD25highCD4+ cells was nega-
tively correlated with the absolute number of sputum
eosinophils (Fig. 3). The frequency of CTLA4+ cells
(r = 0.60, p = 0.009), but not Foxp3+ cells (r = -0.00, p >
0.05), among CD25highCD4+ cells in induced sputum
was also correlated with MCh PC20.
The frequencies of CTLA4+, Foxp3+ and CTLA4+
Foxp3+ cells among CD25lowCD4+ cells in induced
sputum were not associated with %FEV1, sputum
eosinophils, or MCh PC20. The frequency of CTLA4+
cells among CD25+CD4+ cells in induced sputum was
significantly correlated with MCh PC20 (r = 0.47, p =
0.031), but not with the absolute number of eosino-
phils in induced sputum (r = -0.36, p > 0.05) (Table 3).
There was no significant correlation between the fre-
quency of Tregs in peripheral blood, the absolute
number of eosinophils in induced sputum, and the
%FEV1 pred. and MCh PC20 (Table 3).
DISCUSSION
This study has identified that the profiles of three
phenotypes of Tregs, namely CTLA4+CD25highCD4+,
Foxp 3 + CD 25 highCD 4 + , and CTLA 4 + Foxp 3 +
CD25highCD4+ T cells, were significantly decreased in
induced sputum from steroid-naïve adult patients
with stable, mild atopic asthma in comparison with
those in non-atopic healthy subjects.
We have developed a 5-color flow cytometry tech-
nique that allowed identification of CTLA4+, Foxp3+,
and CTLA4+Foxp3+ on CD25+CD4+ cells in both in-
duced sputum and peripheral blood. The technique
was also able to detect not only CD25+CD4+ cells, but
also CD25highCD4+ and CD25lowCD4+ cells.
CD25highCD4+ cells were recognized as Tregs, but
CD25lowCD4+ cells were activated effector or memory
T cells that lack Treg function.17,18 In our present
study, we found that asthmatics had significantly
higher frequencies of CD25high cells among CD4+
cells in peripheral blood, but not in induced sputum,
relative to controls, although there was no significant
inter-group difference in the frequency of CD25low
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Table　3　Correlations between Tregs, eosinophilic infl ammation, lung function, and AHR in asthmatics (n = 18)
%FEV1 pred, (%) PC20 to MCh, (mg/mL) No. of sputum Eos., (×103/mL, log)
Induced sputum
CD25highCD4+cells
%CTLA4+ cells (%) 0.27 0.60* -0.60*
%Foxp3+ cells (%) 0.31 -0.00 -0.25
%CTLA4+Foxp3+ cells (%) 0.56* 0.53 -0.15
CD25lowCD4+ cells
%CTLA4+ cells (%) -0.14 -0.02 -0.00
%Foxp3+ cells (%) 0.07 0.04 -0.30
%CTLA4+Foxp3+ cells (%) 0.16 0.09 -0.22
CD25+CD4+ cells
%CTLA4+ cells (%) -0.24 0.47* -0.36
%Foxp3+ cells (%) -0.02 0.19 -0.08
%CTLA4+Foxp3+ cells (%) 0.40 0.30 -0.21
Peripheral blood
CD25highCD4+cells
%CTLA4+ cells (%) 0.13 0.36 -0.30
%Foxp3+ cells (%) -0.39 -0.26 -0.26
%CTLA4+Foxp3+ cells (%) -0.05 0.12 -0.31
CD25lowCD4+ cells
%CTLA4+ cells (%) 0.21 -0.13 -0.26
%Foxp3+ cells (%) 0.05 -0.08 -0.02
%CTLA4+Foxp3+ cells (%) 0.20 -0.10 -0.15
CD25+CD4+ cells
%CTLA4+ cells (%) 0.21 -0.20 -0.22
%Foxp3+ cells (%) -0.10 -0.12 -0.10
%CTLA4+Foxp3+ cells (%) 0.15 -0.17 -0.13
All data are expressed as correlation r determined by parametric Spearman’s test.
* p < 0.05.
and CD25+ cells among CD4+ cells in induced sputum
or peripheral blood. However, the frequencies of
CD25high, CD25low, and CD25+ cells among CD4+
cells in induced sputum were significantly higher
than in peripheral blood in both asthmatics and con-
trols. In asthmatics, there was a significantly negative
correlation between the frequency of CTLA4+ cells
among CD25highCD4+ cells in induced sputum and
AHR (Fig. 3). The coefficient of the correlation be-
tween CTLA4+ among CD25highCD4+ cells in induced
sputum and AHR was higher than that for CD25+
CD4+ cells and CD25lowCD4+ cells (Table 3).
Although the present study should ideally have ex-
amined both the frequency and absolute number of
Tregs (e.g. Foxp3+CD25highCD4+ cells) in the in-
duced sputum and peripheral blood of asthmatic pa-
tients, CD25+CD4+ cells were a minor population in
induced sputum, as were peripheral CD4+ T cells.
The total cell counts in induced sputum obtained
from asthmatics varied widely. The absolute numbers
of Tregs and CD25+CD4+ cells were dependent on
the total cell counts in induced sputum. Therefore,
we determined the frequency of Tregs (e.g. Foxp3+
CD25high CD4+ cells) in both the induced sputum and
peripheral blood of patients with mild asthma. How-
ever, we did not evaluate the absolute number of
Tregs in the induced sputum and peripheral blood of
these patients. Further analysis will be needed to ver-
ify this issue.
Expression of Foxp3 molecules by helper T cells is
a feature of Tregs.3,28 However, the roles of airway
Foxp3+ Tregs are still unclear. Smyth and cowork-
ers15 demonstrated that the frequency of Foxp3+CD4+
cells in BAL was increased in patients with mild to se-
vere asthma, relative to healthy subjects. However, in
the present study, we recognized CTLA4+ and Foxp3+
on CD25highCD4+ cells as Tregs, and examined in-
duced sputum, as well as selecting patients with mild
atopic asthma, not on any treatment. We found that
asthmatics had a significantly lower frequency of
Foxp 3 + and CTLA 4 + Foxp 3 + cells among
CD25highCD4+ cells in induced sputum than the con-
trols, although there were no significant inter-group
differences in the profiles of CTLA4+, Foxp3+, or
CTLA4+Foxp3+ cells among CD25lowCD4+ cells in in-
duced sputum and peripheral blood. In asthmatics,
the coefficient of correlation between CTLA4+ among
CD25highCD4+ cells in induced sputum and AHR was
Profiles of Tregs in Mild Asthma
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Fig.　3　Correlation between CTLA4+ and Foxp3+ cells among CD25highCD4+ cells in induced 
sputum, eosinophils in induced sputum and AHR in asthmatics. Panels show the correlation be-
tween the frequency (%) of CTLA4+ and Foxp3+ cells among CD25highCD4+ cells in induced spu-
tum, and the absolute number (×103/mL, log) of eosinophils in induced sputum (a) and PC20 MCh 
(mg/mL) (b) in asthmatics (n = 18). The frequency of CTAL4+ (r = -0.60, p = 0.008), but not 
Foxp3+ (r = -0.25, p > 0.05) cells, among CD25highCD4+ cells in induced sputum was negatively 
associated with the absolute number of eosinophils in induced sputum. The frequency of CTLA4+ 
(r = 0.60, p = 0.009), but not Foxp3+ (r = -0.00, p > 0.05) cells, among CD25highCD4+ cells in in-
duced sputum was positively associated with AHR.
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higher than that of CD25+CD4+ cells and
CD25lowCD4+ cells. In addition, there were obvious
differences in the profiles of these phenotypes in in-
duced sputum and peripheral blood between asthmat-
ics and controls. In particular, asthmatics had low and
high frequencies of Foxp3+CD25highCD4+ cells in the
airway and peripheral blood, respectively; whereas in
controls, an opposite tendency was observed. Infor-
mation on the numbers of Tregs in the airway (in-
duced sputum) in asthmatics may be more important
than that in the circulating peripheral blood. Our re-
sults suggest that airway Foxp3+CD25highCD4+ cells,
but not CTLA4+CD25highCD4+, cells may be associ-
ated with the pathogenesis or development of atopic
asthma.
Surprisingly, the frequency of CTLA4+, but not
Foxp 3 + and CTLA 4 + Foxp 3 + cells, among
CD25highCD4+ cells in induced sputum was associ-
ated with AHR in asthmatics. A low frequency of
CTLA4+ cells among CD25highCD4+ cells was also as-
sociated with airway eosinophilic inflammation.
CTLA4 is a potent T-cell down-regulatory molecule
expressed by naturally occurring Tregs during pe-
ripheral immune responses. Polymorphism of the
CTLA4 gene may be associated with AHR and dis-
ease severity in asthma.24,29 Thus, these results sug-
gest that airway CTLA4+CD25highCD4+ cells may play
a role in atopic asthma, modifying features such as
airway eosinophilic inflammation and AHR.
CTLA4 is required for the function of Foxp3-
expressing Tregs.25,30 The CTLA4 and Foxp3 mole-
cules of Tregs mutually control the function of the
other.26,31 CTLA4 expression on natural occurring
Foxp3+ Tregs may reveal opposing effects of costimu-
lation modulators on the steady-state level and quality
of Tregs.27,32 Interaction between airway CTLA4 and
Foxp3 protein expression on CD25highCD4+ cells is
also marked in asthmatics. Here we found that airway
CTLA4+Foxp3+ cells, but not CTLA4+ and Foxp3+,
cells were associated with %FEV1 pred. in asthmatics.
It is known that glucocorticosteroids enhance the
expression of Foxp3 protein on CD25highCD4+ cells in
asthmatics.10,13,28,33 We previously demonstrated that
inhaled corticosteroids increased sputum CTLA4+
CD25+CD4+ cells, along with an increase in the level
of IL-10 in patients with mild asthma.9,14 CD80CD86
molecules enhance the expression of CTLA4.29,30,34,35
Immunotherapy against specific allergens has also
Kawayama T et al.
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been shown to significantly increase Foxp3+ Tregs
cells, with the presence of IL-10 and TGF-beta, lead-
ing to improvement of asthma control and quality of
life in allergic subjects.31,36 Enhancement of airway
CTLA4 and Foxp3 molecules on T cells may contrib-
ute to asthma control.32,37 On the basis of the known
data, therefore, in the present study we carefully ex-
cluded asthmatics that were using inhaled corti-
costeroids.
In summary, the present findings suggest that it
would be better to define CD25highCD4+ cells as
Tregs, rather than CD25low or CD25+CD4+ cells, in
patients with atopic asthma. Information on airway
Tregs in asthmatics is more relevant than that for cir-
culating Tregs, not only. Airway CTLA4+ Tregs ap-
pear to contribute to airway eosinophilic inflamma-
tion and AHR.
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